Training programs for Alzheimer's disease research involving communities and interdisciplinary approaches
Official title: Intergenerational Community Driven Training in Alzheimer's Disease Research: An AI+X Approach
Funded at Arizona State University-Tempe Campus · NIH-10934138 · Data updated 2026-11-12
This study is creating a special training program for future researchers to help them learn how to better understand and treat Alzheimer's Disease, with support from experts and real-life experiences to make a positive impact on the community.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project start | September 15, 2024 |
| Project end | September 14, 2029 |
| Funding year | 2024 |
| Award (this year) | $340,632 |
| NIH project number | 1T32AG082658-01A1 |
| Project ID | NIH-10934138 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals interested in Alzheimer's disease, particularly those from diverse backgrounds who can contribute to community-driven research.
✕Less likely to help
Patients who are not affected by Alzheimer's disease or related dementias may not receive direct benefits from this research.
What this research studies
This research focuses on developing an interdisciplinary training program aimed at preparing future researchers to address Alzheimer's Disease (AD) and related dementias. It involves collaboration between Arizona State University and various clinical and research institutions, providing trainees with mentorship from experts in diverse fields such as clinical science, data science, and drug discovery. The program emphasizes community engagement and real-life experiences, allowing trainees to understand the socio-demographic and lifestyle factors that influence AD. By fostering a workforce equipped to translate research into practice, this initiative aims to enhance the understanding and treatment of Alzheimer's Disease.
Why it matters
Potential benefit: If successful, this research could lead to a more skilled workforce capable of advancing Alzheimer's disease research and improving patient care.
How similar studies have gone: Previous research has shown success in community-driven training approaches in other health fields, suggesting potential for similar outcomes in Alzheimer's research.
Where this research is happening
-
Arizona State University-Tempe Campus
Tempe, United States Active
Researchers
- Principal investigator: Wu, Teresa — Arizona State University-Tempe Campus
- Study coordinator: Wu, Teresa
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.